CBUS
Price
$2.84
Change
+$0.20 (+7.58%)
Updated
Dec 23 closing price
SLDB
Price
$4.10
Change
-$0.06 (-1.44%)
Updated
Dec 23 closing price
Ad is loading...

CBUS vs SLDB

Header iconCBUS vs SLDB Comparison
Open Charts CBUS vs SLDBBanner chart's image
Cibus
Price$2.84
Change+$0.20 (+7.58%)
Volume$239.65K
CapitalizationN/A
Solid Biosciences
Price$4.10
Change-$0.06 (-1.44%)
Volume$610K
CapitalizationN/A
CBUS vs SLDB Comparison Chart
Loading...
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CBUS vs. SLDB commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBUS is a Hold and SLDB is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Dec 24, 2024
Stock price -- (CBUS: $2.84 vs. SLDB: $4.10)
Brand notoriety: CBUS and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CBUS: 157% vs. SLDB: 188%
Market capitalization -- CBUS: $75.13M vs. SLDB: $163.81M
CBUS [@Biotechnology] is valued at $75.13M. SLDB’s [@Biotechnology] market capitalization is $163.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBUS’s FA Score shows that 1 FA rating(s) are green whileSLDB’s FA Score has 2 green FA rating(s).

  • CBUS’s FA Score: 1 green, 4 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, SLDB is a better buy in the long-term than CBUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBUS’s TA Score shows that 4 TA indicator(s) are bullish while SLDB’s TA Score has 4 bullish TA indicator(s).

  • CBUS’s TA Score: 4 bullish, 6 bearish.
  • SLDB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLDB is a better buy in the short-term than CBUS.

Price Growth

CBUS (@Biotechnology) experienced а -26.99% price change this week, while SLDB (@Biotechnology) price change was -10.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.75%. For the same industry, the average monthly price growth was -2.52%, and the average quarterly price growth was +3.67%.

Reported Earning Dates

CBUS is expected to report earnings on Aug 09, 2023.

SLDB is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (-1.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLDB($164M) has a higher market cap than CBUS($75.1M). SLDB YTD gains are higher at: -33.225 vs. CBUS (-85.540). SLDB has higher annual earnings (EBITDA): -108.63M vs. CBUS (-492.98M). SLDB has more cash in the bank: 171M vs. CBUS (28.8M). SLDB has less debt than CBUS: SLDB (24.7M) vs CBUS (36.7M). CBUS has higher revenues than SLDB: CBUS (4.15M) vs SLDB (0).
CBUSSLDBCBUS / SLDB
Capitalization75.1M164M46%
EBITDA-492.98M-108.63M454%
Gain YTD-85.540-33.225257%
P/E RatioN/AN/A-
Revenue4.15M0-
Total Cash28.8M171M17%
Total Debt36.7M24.7M149%
FUNDAMENTALS RATINGS
CBUS vs SLDB: Fundamental Ratings
CBUS
SLDB
OUTLOOK RATING
1..100
5469
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
9689
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
9575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CBUS's Valuation (18) in the null industry is in the same range as SLDB (22) in the Biotechnology industry. This means that CBUS’s stock grew similarly to SLDB’s over the last 12 months.

CBUS's Profit vs Risk Rating (100) in the null industry is in the same range as SLDB (100) in the Biotechnology industry. This means that CBUS’s stock grew similarly to SLDB’s over the last 12 months.

SLDB's SMR Rating (98) in the Biotechnology industry is in the same range as CBUS (99) in the null industry. This means that SLDB’s stock grew similarly to CBUS’s over the last 12 months.

SLDB's Price Growth Rating (89) in the Biotechnology industry is in the same range as CBUS (96) in the null industry. This means that SLDB’s stock grew similarly to CBUS’s over the last 12 months.

SLDB's P/E Growth Rating (3) in the Biotechnology industry is significantly better than the same rating for CBUS (100) in the null industry. This means that SLDB’s stock grew significantly faster than CBUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBUSSLDB
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 16 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FHCIX70.450.44
+0.63%
Fidelity Advisor Health Care I
FSHCX111.790.33
+0.30%
Fidelity Select Health Care Svcs Port
WOOQX18.430.02
+0.11%
JPMorgan SMID Cap Equity R4
RPMMX17.73-0.02
-0.11%
Reinhart Mid Cap PMV Inv
CMRGX9.69-0.23
-2.32%
Calamos Merger Arbitrage I

CBUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBUS has been loosely correlated with PSTX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CBUS jumps, then PSTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBUS
1D Price
Change %
CBUS100%
+7.37%
PSTX - CBUS
35%
Loosely correlated
+0.32%
SLDB - CBUS
32%
Poorly correlated
-1.44%
ETNB - CBUS
32%
Poorly correlated
+0.63%
MGTX - CBUS
32%
Poorly correlated
-0.98%
ADPT - CBUS
31%
Poorly correlated
-1.10%
More

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with ACLX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-1.44%
ACLX - SLDB
42%
Loosely correlated
+1.65%
TRDA - SLDB
41%
Loosely correlated
-0.74%
ABOS - SLDB
41%
Loosely correlated
-4.32%
INZY - SLDB
40%
Loosely correlated
+0.67%
MGTX - SLDB
38%
Loosely correlated
-0.98%
More